Company Overview - Jiangsu Hualv Biotechnology Group Co., Ltd. is located at 88 Lvdou Avenue, Siyang County, Jiangsu Province, established on June 8, 2010, and listed on April 12, 2021. The company's main business involves the research, industrial cultivation, and sales of edible mushrooms [1]. Financial Performance - For the first half of 2025, Hualv Biotechnology achieved operating revenue of CNY 499 million, representing a year-on-year growth of 7.78%. However, the net profit attributable to the parent company was a loss of CNY 53.69 million, a decrease of 19.79% compared to the previous period [2]. - Cumulatively, since its A-share listing, Hualv Biotechnology has distributed a total of CNY 76.79 million in dividends, with CNY 46.45 million distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, the number of shareholders of Hualv Biotechnology reached 11,400, an increase of 11.49% from the previous period. The average number of circulating shares per person decreased by 10.31% to 8,162 shares [2]. - Among the top ten circulating shareholders, CITIC Prudential Multi-Strategy Mixed Fund (LOF) A ranked as the third-largest shareholder, holding 2.0213 million shares, an increase of 1.2423 million shares from the previous period [3]. Financing and Trading Activity - On August 26, Hualv Biotechnology's stock price increased by 0.78%, with a trading volume of CNY 50.68 million. The financing buy-in amount for the day was CNY 7.0463 million, while the financing repayment was CNY 5.4802 million, resulting in a net financing buy-in of CNY 1.5662 million. The total financing and securities lending balance reached CNY 48.173 million, accounting for 2.57% of the circulating market value, which is above the 70th percentile level over the past year [1]. - In terms of securities lending, there were no shares sold or repaid on August 26, with the securities lending balance also at zero, indicating a high level of inactivity in this area, exceeding the 90th percentile level over the past year [1].
华绿生物8月26日获融资买入704.63万元,融资余额4817.30万元